December 02, 2022, Medscape
How Blunt Is Too Blunt for Informed Consent?
David L. Feldman, MD, MBA, FACS, Chief Medical Officer for The Doctors Company and TDC Group, discusses the critical role of effective communication to ensure patient understanding in the informed consent process.
Search
Professional Education
Artificial Intelligence: Harnessing AI to Augment Care
Artificial intelligence offers tools that can enable us to regain time to focus on our patients and restore joy to the practice of medicine.
Disclosure Resources Appendix 4: Disclosure Meeting Protocol
Follow these protocols when having disclosure meetings with patients.
INSIGHT Programs
Our Patient Safety INSIGHT Services take a data-driven, collaborative approach to help you reduce adverse events while increasing patient safety and satisfaction.
Sep 14, 2020
Hospitalist Closed Claims Study
This review of 238 closed hospitalist claims identifies top allegations and factors contributing to patient injury.
Oct 02, 2020
Oncology Closed Claims Study
The Doctors Company conducted a review of medical and surgical oncology claims that closed between 2012 and 2018. This study was based on claims and lawsuits filed against the more than 500 oncologists insured by The Doctors Company.
Physician-Owned Carriers Invest to Benefit Those Who Are Insured, not Shareholders
Physicians should understand the risks of their medical malpractice carrier’s investments and make sure they are covered by an insurer who has their interests at heart and, therefore, takes a prudent and relatively conservative approach to investing.
Medical Practice Coverages
In today’s healthcare environment, the challenges of running a medical group are complex. The Doctors Company offers consultative, customized, and innovative solutions to reduce and control costs, manage employee benefits, and safeguard your practice.
MediGuard
MediGuard regulatory risk coverage, part of our medical malpractice insurance policy, provides members with legal representation for administrative actions brought by Medicare/Medicaid, medical licensing boards, credentialing reviews and actions, Professional Review Organizations, federal agencies regarding EMTALA, and the DEA.
